Track topics on Twitter Track topics that are important to you
Progeny bioVentures is a subsidiary of ANGLE Technology Ltd with the remit to establish new companies from the UK bioscience base. Progeny appraises new company opportunities, develops business plans and secures funding from venture capital and other sources. Progeny's financial return depends entirely on the success of the companies it establishes. Equity stakes are negotiated as appropriate with the scientific innovators, the technology source organisation and funding sources.
Progeny provides access to a seasoned management team with in-depth experience of company start-ups and biotech product development. As the new Company develops, Progeny is able to access a fulltime management team through ANGLE Technology.
Progeny has been granted an award under the Department of Trade and Industry’s Biotechnology Mentoring and Incubation (BMI) Challenge in collaboration with University of Bristol and supported by the Universities of Southampton and Edinburgh and the Rowett Research Institute. However, Progeny extends to all UK universities, research institutes and technology source organisations including major corporates.
The Progeny process involves:
·Appraisal and protection of intellectual property and freedom-to-operate.
·Market research, including analysis of competitors market entry barriers
·Raising finance from venture capital and non-dilutive sources.
·Commercial and general management
·Early stage partnering, including licence negotiation and technology acquisition.
·Securing permanent, experienced management to take the Company through to product launch and beyond.
For further information please contact Bill Mullen or Ioan Cleaton Jones on 01483 295830 or at Progeny@ANGLETechnology.com
Surrey Technology CentreSurrey Research Park
Phone: 44 01483 295830
Fax: 44 01483 295836
At the annual Health 2.0 conference in Silicon Valley, a panel of venture capitalists describe areas of health tech that do not appeal to them.
A look at today's forthcoming news stories: GSK has stepped up its drive into emerging markets; an over the counter genetic testing kit is launched in the US, and the head of BioVentures for Global He...
Rigaku is a Diamond Sponsor of the World Customs Organization Technology and Innovation Forum and will present latest handheld threat identification solutions and techniques. Tokyo, Japan (PRWEB) Octo...
NeuroVia Inc. (small-molecule therapeutics for rare CNS diseases) closed a $14mm Series A round co-led by Novartis Venture Fund and Sanofi-Genzyme BioVentures, which both added members to the company ...
“It is believed that environmental and life-style factors, such as diet, plays a critical role in increasing human breast cancer risk, and so we use animal models to reveal the biological mechan...
Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...
In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Don Joseph, CEO of BioVentures for Global Health about the role of BVGH and their new ...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
This article deals with the variation of radon (Rn), thoron (Tn) and their progeny concentrations expressed in terms of equilibrium equivalent concentrations (EERC and EETC), in 40 houses, in four vil...
Piwi family protein Aubergine (Aub) maintains genome integrity in late germ cells of the Drosophila ovary through Piwi-associated RNA-mediated repression of transposon activities. Although it is highl...
The purpose of this study was to compare the biological effects of fractionated doses versus a single dose of high-LET carbon ions in bystander normal cells, and determine the effect on their progeny ...
Inter-specific hybridization and backcrossing commonly occur in plants. The use of progeny generated from inter-specific hybridization and backcrossing has been developed as a novel model system to ex...
Thorium-227 is currently undergoing evaluation as a potential radionuclide for targeted cancer therapy, and as such a high chemical purity of the material is required. To establish a reliable procedur...
The aim of this trial is to determine the safety and tolerability of expanded autologous progeny of an adult CD34+ (haemopoietic) stem cell subset when infused directly into the tibial art...
This research trial studies how well Oncology Research Information Exchange Network (ORIEN) works in improving genetic screening rate in patients with cancer. Implementation of Progeny Gen...
Progeny bioVentures is a subsidiary of ANGLE Technology Ltd with the remit to establish new companies from the UK bioscience base. Progeny appraises new company opportunities, develops business plans...
Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life ...
BioVentures, Inc. is committed to the highest levels of scholarship through the submission of original research to peer reviewed publications and presentation of our data at scientific conferences. In...
Alpine BioVentures is a venture capital firm committed to investing in and building revolutionary healthcare companies. It brings a unique perspective to identify game-changing sc...
We have published hundreds of Progeny bioVentures Limited news stories on BioPortfolio along with dozens of Progeny bioVentures Limited Clinical Trials and PubMed Articles about Progeny bioVentures Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Progeny bioVentures Limited Companies in our database. You can also find out about relevant Progeny bioVentures Limited Drugs and Medications on this site too.
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...